OTC · Financial Statements
Enzo Biochem, Inc. (ENZB) Financial Statements
$0.70
OTC: ENZB
Market Cap $36.59M
Overview Financials Dividend Enzo Biochem, Inc. most recently reported annual revenue of $32.0M, a net loss of $26.0M. Revenue declined at an average annual rate of 17.0% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2020 2021 2022 2023 2024 Revenue $76.0M $118.0M $107.0M $31.0M $32.0M Operating Profit $-24.0M $10.0M $-16.0M $-25.0M $-10.0M Net Profit $-34.0M $3.0M $-23.0M $20.0M $-26.0M EPS $-0.71 $0.07 $-0.46 $-1.27 $-0.51 Op Margin -31.1% 8.4% -14.5% -79.6% -30.8%
Balance Sheet (USD)
Metric 2020 2021 2022 2023 2024 Total Assets $113.0M $114.0M $96.0M $122.0M $86.0M Total Liabilities $54.0M $45.0M $41.0M $43.0M $30.0M Cash $48.0M $14.0M $22.0M $82.0M $52.0M Borrowings $37.0M $23.0M $17.0M $7.0M $4.0M
Cash Flow (USD)
Metric 2020 2021 2022 2023 2024 Operating Cash Flow $-17.0M $0 $-17.0M $-37.0M $-26.0M Investing Cash Flow $-4.0M $-69.0M $22.0M $96.0M $-1.0M Financing Cash Flow $0 $0 $0 $0 $0 Net Cash Flow $-12.0M $-34.0M $8.0M $61.0M $-31.0M Free Cash Flow $-19.0M $-4.0M $-20.0M $-40.0M $-27.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -0.67 FCF Yield -15.58% Quick Ratio 2.50 Interest Coverage — Return 1Y — Return 3Y — Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .